Intravenous iron infusion in patients with heart failure: a systematic review and study-level meta-analysis.

Intravenous iron infusion in patients with HF reduces the composite risk of first hospitalization for HF and CV mortality as well as the risks of first and recurrent hospitalizations for HF, with no effect on all-cause mortality or CV mortality alone.